D
Sell
2/21/2017Upgraded
BG Medicine, Inc. (BGMD) was upgraded to D from D- on 2/21/2017 due to an increase in the volatility index.
D
Sell
11/25/2016Downgrade
BG Medicine, Inc. (BGMD) was downgraded to D- from D on 11/25/2016 due to a decline in the volatility index.
D
Sell
11/10/2016Upgraded
BG Medicine, Inc. (BGMD) was upgraded to D from D- on 11/10/2016 due to an increase in the total return index.
D
Sell
10/26/2016Downgrade
BG Medicine, Inc. (BGMD) was downgraded to D- from D on 10/26/2016 due to a decline in the volatility index.
D
Sell
4/5/2016Upgraded
BG Medicine, Inc. (BGMD) was upgraded to D from D- on 4/5/2016 due to an increase in the solvency index. The quick ratio increased from 1.44 to 1.45.
D
Sell
3/11/2016Downgrade
BG Medicine, Inc. (BGMD) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index and total return index.
D
Sell
11/20/2015Downgrade
BG Medicine, Inc. (BGMD) was downgraded to D from C- on 11/20/2015 due to a significant decline in the efficiency index, growth index and volatility index. Total capital declined 288.3% from -$701 to $1.32M, operating cash flow declined 59.85% from -$827 to -$332, and net income declined 49.58% from -$2.03M to -$1.02M.
C
Hold
8/14/2015Upgraded
BG Medicine, Inc. (BGMD) was upgraded to C- from D on 8/14/2015 due to a significant increase in the efficiency index, growth index and valuation index. Net income increased 50.52% from -$1.35M to -$2.03M, earnings per share increased from -$0.156 to -$0.2344, and total revenue increased 15.56% from $437 to $505.
D
Sell
5/26/2015Upgraded
BG Medicine, Inc. (BGMD) was upgraded to D from D- on 5/26/2015 due to a noticeable increase in the solvency index and valuation index. Debt to equity declined from 5.31 to -3.28.
D
Sell
5/14/2015Downgrade
BG Medicine, Inc. (BGMD) was downgraded to D- from D on 5/14/2015 due to a decline in the total return index and volatility index.
D
Sell
4/29/2015Upgraded
BG Medicine, Inc. (BGMD) was upgraded to D from D- on 4/29/2015 due to an increase in the volatility index and valuation index.
D
Sell
4/2/2015Downgrade
BG Medicine, Inc. (BGMD) was downgraded to D- from D on 4/2/2015 due to a substantial decline in the solvency index, efficiency index and valuation index. Debt to equity increased from 2.39 to 5.31, net income declined 44.93% from -$2.4M to -$1.32M, and total capital declined 38.89% from $5.76M to $3.52M.
